Evidence for purinergic neurotransmission in the urinary bladder of pithed rats
The purpose of this study was to investigate the contribution of adenosine-5′-triphosphate (ATP) to segmental (L6-S2) spinal electrical stimulation evoked increases in intra-vesical pressure in pithed rats. Exogenous ATP and substance P produced dose-dependent increases in intra-vesical pressure (ED...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 1998-05, Vol.349 (1), p.75-82 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 82 |
---|---|
container_issue | 1 |
container_start_page | 75 |
container_title | European journal of pharmacology |
container_volume | 349 |
creator | Hegde, Sharath S Mandel, Dan A Wilford, Mary R Briaud, Stephanie Ford, Anthony P.D.W Eglen, Richard M |
description | The purpose of this study was to investigate the contribution of adenosine-5′-triphosphate (ATP) to segmental (L6-S2) spinal electrical stimulation evoked increases in intra-vesical pressure in pithed rats. Exogenous ATP and substance P produced dose-dependent increases in intra-vesical pressure (ED
10 mmHg (dose required to elicit 10 mmHg increase in intra-vesical pressure)=1.7 mg/kg and 1.1
μg/kg, i.v., respectively). Desensitisation (or antagonism) of P
2x purinoceptors with
α,
β-methylene ATP (
α,
β-meATP; 30
μg/kg per min, i.v.) or pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS; 10 mg/kg, i.v.) significantly (
p8 and 3.6-fold increase in ED
10 mmHg, respectively) but had no significant effect on intra-vesical pressure responses to substance P. Spinal stimulation evoked frequency-dependent increases in intra-vesical pressure (EF
20 mmHg (frequency required to produce 20 mmHg increase in intra-vesical pressure)=3.4 Hz). Blockade of muscarinic cholinoceptors and adrenoceptors with atropine (3 mg/kg, i.v.), propranolol (3 mg/kg, i.v.) and phentolamine (10 mg/kg, i.v.) produced marginal attenuation of the intra-vesical pressure responses to spinal stimulation indicating a major non-adrenergic non-cholinergic (NANC) component in the overall response. The NANC responses were significantly (
p2.6-fold increase in EF
20 mmHg), consistent with involvement of a purinergic neurotransmitter, presumably ATP. Comparative studies in young (4–6 months) and old (21–23 months) Fischer rats revealed no age-dependent changes in the relative contribution of the cholinergic and purinergic systems, with the latter being the dominant one. These findings suggest that purinergic neurotransmission, presumably mediated by ATP acting via P
2x purinoceptors, represents a major component of excitatory innervation to the urinary bladder in pithed rats. |
doi_str_mv | 10.1016/S0014-2999(98)00173-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80009167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299998001733</els_id><sourcerecordid>80009167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-c09614b6a5707e6160acf6f5e25df884ba541898f2879283b435442c7384dcd63</originalsourceid><addsrcrecordid>eNqFkE1PAyEURYnRaP34CSYsjNHFKAwMAytjmvqRmHShrgkDD8VMZyrMNPHfS23TrStC7nnw7kHonJIbSqi4fSWE8qJUSl0peZ0vNSvYHppQWauC1LTcR5MdcoSOU_oihFSqrA7RoRJCcaUmaD5bBQedBez7iJdjDB3Ej2BxB2Psh2i6tAgphb7DocPDJ-A1YuIPblrjHETce7wMOXA4miGdogNv2gRn2_MEvT_M3qZPxcv88Xl6_1JYJtVQWKIE5Y0wVU1qEFQQY73wFZSV81LyxlScSiV9mduUkjWcVZyXtmaSO-sEO0GXm3eXsf8eIQ06r2mhbU0H_Zi0zF0VFXUGqw1oY59SBK-XMSxyAU2JXovUfyL12pJWUv-J1CzPnW8_GJsFuN3U1lzOL7a5Sda0PpuyIe2wkgnBOMnY3QaDLGMVIOpkw9q3CxHsoF0f_lnkF4C1jyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80009167</pqid></control><display><type>article</type><title>Evidence for purinergic neurotransmission in the urinary bladder of pithed rats</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hegde, Sharath S ; Mandel, Dan A ; Wilford, Mary R ; Briaud, Stephanie ; Ford, Anthony P.D.W ; Eglen, Richard M</creator><creatorcontrib>Hegde, Sharath S ; Mandel, Dan A ; Wilford, Mary R ; Briaud, Stephanie ; Ford, Anthony P.D.W ; Eglen, Richard M</creatorcontrib><description>The purpose of this study was to investigate the contribution of adenosine-5′-triphosphate (ATP) to segmental (L6-S2) spinal electrical stimulation evoked increases in intra-vesical pressure in pithed rats. Exogenous ATP and substance P produced dose-dependent increases in intra-vesical pressure (ED
10 mmHg (dose required to elicit 10 mmHg increase in intra-vesical pressure)=1.7 mg/kg and 1.1
μg/kg, i.v., respectively). Desensitisation (or antagonism) of P
2x purinoceptors with
α,
β-methylene ATP (
α,
β-meATP; 30
μg/kg per min, i.v.) or pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS; 10 mg/kg, i.v.) significantly (
p<0.05) antagonized the intra-vesical pressure responses to ATP (>8 and 3.6-fold increase in ED
10 mmHg, respectively) but had no significant effect on intra-vesical pressure responses to substance P. Spinal stimulation evoked frequency-dependent increases in intra-vesical pressure (EF
20 mmHg (frequency required to produce 20 mmHg increase in intra-vesical pressure)=3.4 Hz). Blockade of muscarinic cholinoceptors and adrenoceptors with atropine (3 mg/kg, i.v.), propranolol (3 mg/kg, i.v.) and phentolamine (10 mg/kg, i.v.) produced marginal attenuation of the intra-vesical pressure responses to spinal stimulation indicating a major non-adrenergic non-cholinergic (NANC) component in the overall response. The NANC responses were significantly (
p<0.05) antagonized by
α,
β-meATP (30
μg/kg per min, i.v.) and PPADS (10 mg/kg, i.v.) (>2.6-fold increase in EF
20 mmHg), consistent with involvement of a purinergic neurotransmitter, presumably ATP. Comparative studies in young (4–6 months) and old (21–23 months) Fischer rats revealed no age-dependent changes in the relative contribution of the cholinergic and purinergic systems, with the latter being the dominant one. These findings suggest that purinergic neurotransmission, presumably mediated by ATP acting via P
2x purinoceptors, represents a major component of excitatory innervation to the urinary bladder in pithed rats.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(98)00173-3</identifier><identifier>PMID: 9669499</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adenosine Triphosphate - analogs & derivatives ; Adenosine Triphosphate - pharmacology ; Adenosine Triphosphate - physiology ; Adrenergic Antagonists - pharmacology ; Aging - physiology ; Animals ; Atropine - pharmacology ; Biological and medical sciences ; Bladder ; Blood Pressure - drug effects ; Decerebrate State ; Electric Stimulation ; Female ; Fundamental and applied biological sciences. Psychology ; Ganglionic Blockers - pharmacology ; Muscarinic Antagonists - pharmacology ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; Muscle, Smooth - physiology ; Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ ; PPADS (pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid), α, β-methylene ATP ; Pressure ; Purinergic ; Purinergic P2 Receptor Antagonists ; Purinoceptor ; Pyridoxal Phosphate - analogs & derivatives ; Pyridoxal Phosphate - pharmacology ; Rats ; Rats, Inbred F344 ; Rats, Sprague-Dawley ; Receptors, Purinergic - physiology ; Spinal Nerves - physiology ; Substance P - pharmacology ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology ; Urinary Bladder - drug effects ; Urinary Bladder - innervation ; Urinary Bladder - physiology ; Vertebrates: nervous system and sense organs ; Vertebrates: urinary system</subject><ispartof>European journal of pharmacology, 1998-05, Vol.349 (1), p.75-82</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-c09614b6a5707e6160acf6f5e25df884ba541898f2879283b435442c7384dcd63</citedby><cites>FETCH-LOGICAL-c389t-c09614b6a5707e6160acf6f5e25df884ba541898f2879283b435442c7384dcd63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0014-2999(98)00173-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2366340$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9669499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hegde, Sharath S</creatorcontrib><creatorcontrib>Mandel, Dan A</creatorcontrib><creatorcontrib>Wilford, Mary R</creatorcontrib><creatorcontrib>Briaud, Stephanie</creatorcontrib><creatorcontrib>Ford, Anthony P.D.W</creatorcontrib><creatorcontrib>Eglen, Richard M</creatorcontrib><title>Evidence for purinergic neurotransmission in the urinary bladder of pithed rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The purpose of this study was to investigate the contribution of adenosine-5′-triphosphate (ATP) to segmental (L6-S2) spinal electrical stimulation evoked increases in intra-vesical pressure in pithed rats. Exogenous ATP and substance P produced dose-dependent increases in intra-vesical pressure (ED
10 mmHg (dose required to elicit 10 mmHg increase in intra-vesical pressure)=1.7 mg/kg and 1.1
μg/kg, i.v., respectively). Desensitisation (or antagonism) of P
2x purinoceptors with
α,
β-methylene ATP (
α,
β-meATP; 30
μg/kg per min, i.v.) or pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS; 10 mg/kg, i.v.) significantly (
p<0.05) antagonized the intra-vesical pressure responses to ATP (>8 and 3.6-fold increase in ED
10 mmHg, respectively) but had no significant effect on intra-vesical pressure responses to substance P. Spinal stimulation evoked frequency-dependent increases in intra-vesical pressure (EF
20 mmHg (frequency required to produce 20 mmHg increase in intra-vesical pressure)=3.4 Hz). Blockade of muscarinic cholinoceptors and adrenoceptors with atropine (3 mg/kg, i.v.), propranolol (3 mg/kg, i.v.) and phentolamine (10 mg/kg, i.v.) produced marginal attenuation of the intra-vesical pressure responses to spinal stimulation indicating a major non-adrenergic non-cholinergic (NANC) component in the overall response. The NANC responses were significantly (
p<0.05) antagonized by
α,
β-meATP (30
μg/kg per min, i.v.) and PPADS (10 mg/kg, i.v.) (>2.6-fold increase in EF
20 mmHg), consistent with involvement of a purinergic neurotransmitter, presumably ATP. Comparative studies in young (4–6 months) and old (21–23 months) Fischer rats revealed no age-dependent changes in the relative contribution of the cholinergic and purinergic systems, with the latter being the dominant one. These findings suggest that purinergic neurotransmission, presumably mediated by ATP acting via P
2x purinoceptors, represents a major component of excitatory innervation to the urinary bladder in pithed rats.</description><subject>Adenosine Triphosphate - analogs & derivatives</subject><subject>Adenosine Triphosphate - pharmacology</subject><subject>Adenosine Triphosphate - physiology</subject><subject>Adrenergic Antagonists - pharmacology</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Atropine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bladder</subject><subject>Blood Pressure - drug effects</subject><subject>Decerebrate State</subject><subject>Electric Stimulation</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ganglionic Blockers - pharmacology</subject><subject>Muscarinic Antagonists - pharmacology</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>Muscle, Smooth - physiology</subject><subject>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</subject><subject>PPADS (pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid), α, β-methylene ATP</subject><subject>Pressure</subject><subject>Purinergic</subject><subject>Purinergic P2 Receptor Antagonists</subject><subject>Purinoceptor</subject><subject>Pyridoxal Phosphate - analogs & derivatives</subject><subject>Pyridoxal Phosphate - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Purinergic - physiology</subject><subject>Spinal Nerves - physiology</subject><subject>Substance P - pharmacology</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><subject>Urinary Bladder - drug effects</subject><subject>Urinary Bladder - innervation</subject><subject>Urinary Bladder - physiology</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>Vertebrates: urinary system</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PAyEURYnRaP34CSYsjNHFKAwMAytjmvqRmHShrgkDD8VMZyrMNPHfS23TrStC7nnw7kHonJIbSqi4fSWE8qJUSl0peZ0vNSvYHppQWauC1LTcR5MdcoSOU_oihFSqrA7RoRJCcaUmaD5bBQedBez7iJdjDB3Ej2BxB2Psh2i6tAgphb7DocPDJ-A1YuIPblrjHETce7wMOXA4miGdogNv2gRn2_MEvT_M3qZPxcv88Xl6_1JYJtVQWKIE5Y0wVU1qEFQQY73wFZSV81LyxlScSiV9mduUkjWcVZyXtmaSO-sEO0GXm3eXsf8eIQ06r2mhbU0H_Zi0zF0VFXUGqw1oY59SBK-XMSxyAU2JXovUfyL12pJWUv-J1CzPnW8_GJsFuN3U1lzOL7a5Sda0PpuyIe2wkgnBOMnY3QaDLGMVIOpkw9q3CxHsoF0f_lnkF4C1jyI</recordid><startdate>19980515</startdate><enddate>19980515</enddate><creator>Hegde, Sharath S</creator><creator>Mandel, Dan A</creator><creator>Wilford, Mary R</creator><creator>Briaud, Stephanie</creator><creator>Ford, Anthony P.D.W</creator><creator>Eglen, Richard M</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980515</creationdate><title>Evidence for purinergic neurotransmission in the urinary bladder of pithed rats</title><author>Hegde, Sharath S ; Mandel, Dan A ; Wilford, Mary R ; Briaud, Stephanie ; Ford, Anthony P.D.W ; Eglen, Richard M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-c09614b6a5707e6160acf6f5e25df884ba541898f2879283b435442c7384dcd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adenosine Triphosphate - analogs & derivatives</topic><topic>Adenosine Triphosphate - pharmacology</topic><topic>Adenosine Triphosphate - physiology</topic><topic>Adrenergic Antagonists - pharmacology</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Atropine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bladder</topic><topic>Blood Pressure - drug effects</topic><topic>Decerebrate State</topic><topic>Electric Stimulation</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ganglionic Blockers - pharmacology</topic><topic>Muscarinic Antagonists - pharmacology</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>Muscle, Smooth - physiology</topic><topic>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</topic><topic>PPADS (pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid), α, β-methylene ATP</topic><topic>Pressure</topic><topic>Purinergic</topic><topic>Purinergic P2 Receptor Antagonists</topic><topic>Purinoceptor</topic><topic>Pyridoxal Phosphate - analogs & derivatives</topic><topic>Pyridoxal Phosphate - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Purinergic - physiology</topic><topic>Spinal Nerves - physiology</topic><topic>Substance P - pharmacology</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><topic>Urinary Bladder - drug effects</topic><topic>Urinary Bladder - innervation</topic><topic>Urinary Bladder - physiology</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>Vertebrates: urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hegde, Sharath S</creatorcontrib><creatorcontrib>Mandel, Dan A</creatorcontrib><creatorcontrib>Wilford, Mary R</creatorcontrib><creatorcontrib>Briaud, Stephanie</creatorcontrib><creatorcontrib>Ford, Anthony P.D.W</creatorcontrib><creatorcontrib>Eglen, Richard M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hegde, Sharath S</au><au>Mandel, Dan A</au><au>Wilford, Mary R</au><au>Briaud, Stephanie</au><au>Ford, Anthony P.D.W</au><au>Eglen, Richard M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for purinergic neurotransmission in the urinary bladder of pithed rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1998-05-15</date><risdate>1998</risdate><volume>349</volume><issue>1</issue><spage>75</spage><epage>82</epage><pages>75-82</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The purpose of this study was to investigate the contribution of adenosine-5′-triphosphate (ATP) to segmental (L6-S2) spinal electrical stimulation evoked increases in intra-vesical pressure in pithed rats. Exogenous ATP and substance P produced dose-dependent increases in intra-vesical pressure (ED
10 mmHg (dose required to elicit 10 mmHg increase in intra-vesical pressure)=1.7 mg/kg and 1.1
μg/kg, i.v., respectively). Desensitisation (or antagonism) of P
2x purinoceptors with
α,
β-methylene ATP (
α,
β-meATP; 30
μg/kg per min, i.v.) or pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS; 10 mg/kg, i.v.) significantly (
p<0.05) antagonized the intra-vesical pressure responses to ATP (>8 and 3.6-fold increase in ED
10 mmHg, respectively) but had no significant effect on intra-vesical pressure responses to substance P. Spinal stimulation evoked frequency-dependent increases in intra-vesical pressure (EF
20 mmHg (frequency required to produce 20 mmHg increase in intra-vesical pressure)=3.4 Hz). Blockade of muscarinic cholinoceptors and adrenoceptors with atropine (3 mg/kg, i.v.), propranolol (3 mg/kg, i.v.) and phentolamine (10 mg/kg, i.v.) produced marginal attenuation of the intra-vesical pressure responses to spinal stimulation indicating a major non-adrenergic non-cholinergic (NANC) component in the overall response. The NANC responses were significantly (
p<0.05) antagonized by
α,
β-meATP (30
μg/kg per min, i.v.) and PPADS (10 mg/kg, i.v.) (>2.6-fold increase in EF
20 mmHg), consistent with involvement of a purinergic neurotransmitter, presumably ATP. Comparative studies in young (4–6 months) and old (21–23 months) Fischer rats revealed no age-dependent changes in the relative contribution of the cholinergic and purinergic systems, with the latter being the dominant one. These findings suggest that purinergic neurotransmission, presumably mediated by ATP acting via P
2x purinoceptors, represents a major component of excitatory innervation to the urinary bladder in pithed rats.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>9669499</pmid><doi>10.1016/S0014-2999(98)00173-3</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 1998-05, Vol.349 (1), p.75-82 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_80009167 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adenosine Triphosphate - analogs & derivatives Adenosine Triphosphate - pharmacology Adenosine Triphosphate - physiology Adrenergic Antagonists - pharmacology Aging - physiology Animals Atropine - pharmacology Biological and medical sciences Bladder Blood Pressure - drug effects Decerebrate State Electric Stimulation Female Fundamental and applied biological sciences. Psychology Ganglionic Blockers - pharmacology Muscarinic Antagonists - pharmacology Muscle, Smooth - drug effects Muscle, Smooth - innervation Muscle, Smooth - physiology Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ PPADS (pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid), α, β-methylene ATP Pressure Purinergic Purinergic P2 Receptor Antagonists Purinoceptor Pyridoxal Phosphate - analogs & derivatives Pyridoxal Phosphate - pharmacology Rats Rats, Inbred F344 Rats, Sprague-Dawley Receptors, Purinergic - physiology Spinal Nerves - physiology Substance P - pharmacology Synaptic Transmission - drug effects Synaptic Transmission - physiology Urinary Bladder - drug effects Urinary Bladder - innervation Urinary Bladder - physiology Vertebrates: nervous system and sense organs Vertebrates: urinary system |
title | Evidence for purinergic neurotransmission in the urinary bladder of pithed rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20purinergic%20neurotransmission%20in%20the%20urinary%20bladder%20of%20pithed%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Hegde,%20Sharath%20S&rft.date=1998-05-15&rft.volume=349&rft.issue=1&rft.spage=75&rft.epage=82&rft.pages=75-82&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(98)00173-3&rft_dat=%3Cproquest_cross%3E80009167%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80009167&rft_id=info:pmid/9669499&rft_els_id=S0014299998001733&rfr_iscdi=true |